AnGes, Inc. (4563.T)
JPY 50.0
(2.04%)
JPY 50.0
(2.04%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.61 Billion JPY | 60.23% |
| 2022 | 1 Billion JPY | -17.59% |
| 2021 | 1.22 Billion JPY | 2.72% |
| 2020 | 1.19 Billion JPY | 86.7% |
| 2019 | 638.09 Million JPY | -36.66% |
| 2018 | 1 Billion JPY | -35.95% |
| 2017 | 1.57 Billion JPY | 34.27% |
| 2016 | 1.17 Billion JPY | 75.5% |
| 2015 | 667.4 Million JPY | 86.85% |
| 2014 | 357.19 Million JPY | -42.25% |
| 2013 | 618.54 Million JPY | -4.98% |
| 2012 | 650.94 Million JPY | 6.75% |
| 2011 | 609.79 Million JPY | -4.06% |
| 2010 | 635.61 Million JPY | 23.26% |
| 2009 | 515.66 Million JPY | -12.29% |
| 2008 | 587.94 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.3 Billion JPY | -32.8% |
| 2024 Q1 | 1.93 Billion JPY | 19.98% |
| 2023 Q1 | 1.55 Billion JPY | 53.86% |
| 2023 Q2 | 1.54 Billion JPY | -0.39% |
| 2023 FY | 1.61 Billion JPY | 60.23% |
| 2023 Q4 | 1.61 Billion JPY | 5.54% |
| 2023 Q3 | 1.53 Billion JPY | -0.93% |
| 2022 Q3 | 1.51 Billion JPY | -9.02% |
| 2022 Q2 | 1.66 Billion JPY | -2.3% |
| 2022 Q1 | 1.7 Billion JPY | 39.52% |
| 2022 FY | 1 Billion JPY | -17.59% |
| 2022 Q4 | 1 Billion JPY | -33.55% |
| 2021 Q2 | 1.11 Billion JPY | -6.85% |
| 2021 Q3 | 980.62 Million JPY | -12.18% |
| 2021 Q4 | 1.22 Billion JPY | 24.79% |
| 2021 FY | 1.22 Billion JPY | 2.72% |
| 2021 Q1 | 1.19 Billion JPY | 0.62% |
| 2020 FY | 1.19 Billion JPY | 86.7% |
| 2020 Q3 | 1.08 Billion JPY | 64.93% |
| 2020 Q2 | 654.89 Million JPY | 7.51% |
| 2020 Q4 | 1.19 Billion JPY | 10.29% |
| 2020 Q1 | 609.13 Million JPY | -4.54% |
| 2019 Q4 | 638.09 Million JPY | -8.37% |
| 2019 FY | 638.09 Million JPY | -36.66% |
| 2019 Q1 | 827.12 Million JPY | -17.89% |
| 2019 Q2 | 705.69 Million JPY | -14.68% |
| 2019 Q3 | 696.4 Million JPY | -1.32% |
| 2018 Q3 | 1.38 Billion JPY | -9.35% |
| 2018 Q1 | 1.47 Billion JPY | -6.13% |
| 2018 Q2 | 1.52 Billion JPY | 3.31% |
| 2018 FY | 1 Billion JPY | -35.95% |
| 2018 Q4 | 1 Billion JPY | -27.13% |
| 2017 Q2 | 1.07 Billion JPY | -6.22% |
| 2017 FY | 1.57 Billion JPY | 34.27% |
| 2017 Q4 | 1.57 Billion JPY | -5.17% |
| 2017 Q3 | 1.65 Billion JPY | 53.73% |
| 2017 Q1 | 1.15 Billion JPY | -1.79% |
| 2016 Q3 | 1.03 Billion JPY | 3.87% |
| 2016 Q1 | 735.08 Million JPY | 10.14% |
| 2016 FY | 1.17 Billion JPY | 75.5% |
| 2016 Q4 | 1.17 Billion JPY | 13.02% |
| 2016 Q2 | 997.72 Million JPY | 35.73% |
| 2015 Q1 | 365.15 Million JPY | 2.23% |
| 2015 FY | 667.4 Million JPY | 86.85% |
| 2015 Q3 | 843.88 Million JPY | 63.99% |
| 2015 Q2 | 514.6 Million JPY | 40.93% |
| 2015 Q4 | 667.4 Million JPY | -20.91% |
| 2014 Q1 | 615.59 Million JPY | -0.48% |
| 2014 Q4 | 357.19 Million JPY | -20.25% |
| 2014 Q3 | 447.87 Million JPY | -40.62% |
| 2014 Q2 | 754.21 Million JPY | 22.52% |
| 2014 FY | 357.19 Million JPY | -42.25% |
| 2013 Q2 | 709.15 Million JPY | 14.84% |
| 2013 Q3 | 696.55 Million JPY | -1.78% |
| 2013 Q4 | 618.54 Million JPY | -11.2% |
| 2013 FY | 618.54 Million JPY | -4.98% |
| 2013 Q1 | 617.5 Million JPY | -5.14% |
| 2012 Q4 | 650.94 Million JPY | -5.38% |
| 2012 Q3 | 687.92 Million JPY | 4.2% |
| 2012 Q2 | 660.17 Million JPY | 12.48% |
| 2012 Q1 | 586.95 Million JPY | -3.75% |
| 2012 FY | 650.94 Million JPY | 6.75% |
| 2011 FY | 609.79 Million JPY | -4.06% |
| 2011 Q3 | 647.49 Million JPY | -2.51% |
| 2011 Q2 | 664.17 Million JPY | -4.18% |
| 2011 Q4 | 609.79 Million JPY | -5.82% |
| 2011 Q1 | 693.13 Million JPY | 9.05% |
| 2010 Q2 | 745 Million JPY | 28.13% |
| 2010 Q1 | 581.42 Million JPY | 12.75% |
| 2010 FY | 635.61 Million JPY | 23.26% |
| 2010 Q3 | 698.08 Million JPY | -6.3% |
| 2010 Q4 | 635.61 Million JPY | -8.95% |
| 2009 Q3 | 536.32 Million JPY | -8.37% |
| 2009 FY | 515.66 Million JPY | -12.29% |
| 2009 Q2 | 585.28 Million JPY | -5.74% |
| 2009 Q1 | 620.92 Million JPY | 0.0% |
| 2009 Q4 | 515.66 Million JPY | -3.85% |
| 2008 FY | 587.94 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | -136.572% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -8912.271% |
| GNI Group Ltd. | 2.33 Billion JPY | 30.67% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 27.467% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -2294.467% |
| Soiken Holdings Inc. | 1.12 Billion JPY | -44.157% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -1460.656% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -2083.557% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 44.34% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | -401.94% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -878057.609% |
| Carna Biosciences, Inc. | 140.14 Million JPY | -1052.997% |
| CanBas Co., Ltd. | 728 Thousand JPY | -221851.923% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -1739.011% |
| RaQualia Pharma Inc. | 147.93 Million JPY | -992.214% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -2420.489% |
| Kidswell Bio Corporation | 875.65 Million JPY | -84.526% |
| PeptiDream Inc. | 2.4 Billion JPY | 32.791% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -30147.286% |
| Ribomic Inc. | 2.27 Million JPY | -70955.849% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -161580999900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -4388.361% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -5471.759% |
| CellSource Co., Ltd. | 305.92 Million JPY | -428.172% |
| FunPep Company Limited | 25.54 Million JPY | -6226.338% |
| Kringle Pharma, Inc. | 364.05 Million JPY | -343.836% |
| Stella Pharma Corporation | 1.11 Billion JPY | -44.753% |
| TMS Co., Ltd. | 50.02 Million JPY | -3130.005% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -7630.778% |
| Cuorips Inc. | 1.04 Million JPY | -154819.463% |
| K Pharma,Inc. | 10.79 Million JPY | -14869.52% |
| Takara Bio Inc. | 11.85 Billion JPY | 86.364% |
| ReproCELL Incorporated | 248.14 Million JPY | -551.169% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | -258.601% |
| StemCell Institute Inc. | 42.26 Million JPY | -3723.316% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | -606.937% |
| CellSeed Inc. | 46.19 Million JPY | -3398.106% |